Hank Safferstein
Impact in
- Biological Psychiatry top 10%
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Cholinesterase and Neurodegenerative Diseases 6
-
- Computational Drug Discovery Methods 4
- Co-authors
- Susan M. Catalano (6 shared papers)Nicholas J. Izzo (6 shared papers)Kelsie Mozzoni (5 shared papers)Michael J Grundman (4 shared papers)Steven T. DeKosky (4 shared papers)Lon S. Schneider (3 shared papers)Roger E. Morgan (3 shared papers)Jason D. Lickliter (2 shared papers)
- Journals
- Alzheimer s & Dementia (4 papers)PLoS ONE (2 papers)Journal of Neurochemistry (1 paper)Alzheimer s & Dementia Translational Research & Clinical Interventions (1 paper)Journal of Neuroscience Research (1 paper)
- Partner nations
- United StatesSweden
In The Last Decade
Hank Safferstein
9 papers receiving 633 citations
Peers
Comparison fields: 5 of 107
- Biological Psychiatry 36
- Pharmacology 142
- Cellular and Molecular Neuroscience 151
- Physiology 179
- Neurology 53
Countries citing papers authored by Hank Safferstein
This map shows the geographic impact of Hank Safferstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hank Safferstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hank Safferstein more than expected).
Fields of papers citing papers by Hank Safferstein
This network shows the impact of papers produced by Hank Safferstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hank Safferstein. The network helps show where Hank Safferstein may publish in the future.
Co-authors
The 16 scholars most cited alongside Hank Safferstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 264 | |
| 2 | 2014 | 160 | |
| 3 | 2018 | 90 | |
| 4 | 2021 | 79 | |
| 5 | 2021 | 32 | |
| 6 | 2020 | 22 | |
| 7 | 2016 | 6 | |
| 8 | 2017 | 5 | |
| 9 | 2019 | 3 |
About Hank Safferstein
Hank Safferstein is a scholar working on Pharmacology, Computational Theory and Mathematics, Molecular Biology, Cellular and Molecular Neuroscience and Physiology, having authored 9 papers that have together received 661 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (6 papers), Pharmacological Receptor Mechanisms and Effects (5 papers), Computational Drug Discovery Methods (4 papers), Receptor Mechanisms and Signaling (2 papers), Alzheimer's disease research and treatments (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Epilepsy research and treatment (1 paper) and Attention Deficit Hyperactivity Disorder (1 paper). The work is most often cited by research in Biological Psychiatry (36 citations), Pharmacology (142 citations), Cellular and Molecular Neuroscience (151 citations), Physiology (179 citations) and Neurology (53 citations). Hank Safferstein has collaborated with scholars based in United States and Sweden. Frequent co-authors include Susan M. Catalano, Nicholas J. Izzo, Kelsie Mozzoni, Michael J Grundman, Steven T. DeKosky, Lon S. Schneider, Roger E. Morgan, Jason D. Lickliter, Robert J. Guttendorf and Raymond Yurko. Their work appears in journals such as Alzheimer s & Dementia, PLoS ONE, Journal of Neurochemistry, Alzheimer s & Dementia Translational Research & Clinical Interventions and Journal of Neuroscience Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.